| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $104.1M | +2.1% |
| Cost of Revenue | $47.5M | +7.6% |
| Gross Profit | $56.6M | -2.2% |
| R&D Expense | $15.9M | +13.9% |
| SG&A Expense | $23.2M | -2.9% |
| Operating Income | -$8.7M | -11.2% |
| Pre-tax Income | -$9.3M | -10.8% |
| Income Tax | $113K | -85.5% |
| Net Income | -$9.4M | -2.6% |
| EPS (Basic) | -$0.74 | -2.8% |
| EPS (Diluted) | -$0.74 | -2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.8M | +19.8% |
| Accounts Receivable | $23.5M | +19.5% |
| Current Assets | $48.6M | +11.6% |
| Total Assets | $135.8M | -0.8% |
| Current Liabilities | $57.4M | +2.4% |
| Total Liabilities | $63.6M | -1.3% |
| Stockholders' Equity | $72.2M | -0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.3M | -58.1% |
| Capital Expenditures | $4.4M | -29.7% |
| Investing Cash Flow | -$4.5M | +30.7% |
| Financing Cash Flow | -$2.4M | +71.5% |
| Free Cash Flow | $4.9M | -69.5% |